Skip to main content

Advertisement

Table 1 Characteristic of prospective studies

From: Risk-reducing salpingo-oophorectomy: a meta-analysis on impact on ovarian cancer risk and all cause mortality in BRCA 1 and BRCA 2 mutation carriers

Study (country) Patients with/without RRSO Follow-up (years) Age at RRSO (mean)
  All BRCA1 BRCA2   
Kauff et al. [13] (USA) 509/283 325/173 184/110 3.4 47.1
Domchek et al. [10] (USA) 939/1678 681/1006 258/672 6.2 43.2
Finch et al. [6] (USA-Europe) 3513/2270 2649/1824 864/446 5.6 47.75
  1. RRSO: prophylactic salpingo-oophorectomy.